- Home
- STXS
STXS
Stereotaxis Inc.
as 04-25-2025 4:00pm EST
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
| Founded: | 1990 | Country: | United States |
| Employees: | N/A | City: | ST.LOUIS |
| Market Cap: | 151.3M | IPO Year: | 2004 |
| Target Price: | N/A | AVG Volume (30 days): | 422.2K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.54 - $2.72 | Next Earning Date: | 05-12-2025 |
| Revenue: | $26,918,000 | Revenue Growth: | 0.55% |
| Revenue Growth (this year): | 34.9% | Revenue Growth (next year): | 58.64% |
Stock Insider Trading Activity of Stereotaxis Inc. (STXS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Isaac Paul J | STXS | Director | Mar 6 '25 | Buy | $1.80 | 24,788 | $44,836.50 | 49,066 |
Latest Stereotaxis Inc. News
STXS Breaking Stock News: Dive into STXS Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
Thermo Fisher Scientific (TMO) Q1 Earnings and Revenues Beat Estimates
GlobeNewswire
4 days ago
Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025
GlobeNewswire
5 days ago
Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025
Zacks
a month ago
3 Promising Surgical Robotics Stocks to Keep an Eye on in 2025
Insider Monkey
a month ago
Nvidia’s Support Boosts Stereotaxis (STXS) in Advancing Robotic Surgery
Zacks
a month ago
Stereotaxis Jumps 15% on NVIDIA's AI-Driven Collaboration: Is It a Buy Now?
Simply Wall St.
a month ago
March 2025 Penny Stocks With Promising Prospects
GlobeNewswire
a month ago
Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program
Compare STXS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "STXS Stereotaxis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.